Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoltzfus, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoltzfus, R. J.
(Journal of Nutrition. 2001;131:565S-567S.)
© 2001 The American Society for Nutritional Sciences


Supplement

Defining Iron-Deficiency Anemia in Public Health Terms: A Time for Reflection1 ,2

Rebecca J. Stoltzfus

Center for Human Nutrition, Department of International Health, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore MD


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 WHERE HAVE WE COME...
 WHERE HAVE WE COME...
 WHERE DO WE GO...
 REFERENCES
 
This paper provides a historical context for this meeting, which aimed to examine critically the way we have defined iron-deficiency anemia as a public health problem. The terms and concepts used to define the problem are reviewed first, followed by estimates of the global prevalence of the problem from 1985 to 2000. It is argued that recent estimates are not credible and that we must redefine the problem in terms that are important, measurable and addressable. This meeting was designed to take first steps toward that goal, namely, to identify the causal factors (e.g., iron deficiency vs. iron-deficiency anemia vs. severe anemia from any cause) that link iron-deficiency anemia to important health outcomes and to estimate the magnitude of their effects in public health terms.


KEY WORDS: • iron deficiency • anemia • public health • history


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 WHERE HAVE WE COME...
 WHERE HAVE WE COME...
 WHERE DO WE GO...
 REFERENCES
 
The impetus for this meeting was the conviction that we must define the problem of iron-deficiency anemia in terms of its health consequences in human populations. To do this with clarity, we must look critically at the evidence. First, this meeting must be put in historical context. Where have we come from in defining iron-deficiency anemia as a public health problem? Where do we hope to go?


    WHERE HAVE WE COME FROM? TERMS AND CONCEPTS
 TOP
 ABSTRACT
 INTRODUCTION
 WHERE HAVE WE COME...
 WHERE HAVE WE COME...
 WHERE DO WE GO...
 REFERENCES
 
The initial term and concept was nutritional anemias. Although this term is not commonly used today, it lives on in the name of the International Nutritional Anemia Consultative Group (INACG).3 Nutritional anemia was defined in a 1968 WHO technical report as "a condition in which the hemoglobin content of the blood is lower than normal as a result of a deficiency of one or more essential nutrients, regardless of the cause of such deficiency."

To determine which nutritional deficiencies were most responsible, WHO coordinated a series of studies in pregnant women in which anemia, serum folate, transferrin saturation and serum B-12 were assessed. They concluded that "Iron deficiency was present in 40–99% of the pregnant women studied and was undoubtedly responsible for the major proportion of anemia" (WHO 1968Citation ).

The evidence that led them to that conclusion is shown in Figure 1Citation . Certainly the authors were impressed by the prevalence of iron deficiency, which was ~10 times higher than that of folate deficiency or vitamin B-12 deficiency based on their indicators. However, the relation between anemia prevalence and iron deficiency prevalence is not apparent when the data are compared among populations. Within-population correlation coefficients with hemoglobin were published for the study in Vellore, India. There was a strong correlation between hemoglobin and transferrin saturation (r = 0.56, P < 0.001), but the correlation with serum folate was even stronger (r = 0.82, P < 0.001). There was no significant correlation between serum vitamin B-12 and hemoglobin (Baker and DeMaeyer 1979Citation ).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Scatterplot of anemia prevalence vs. iron deficiency prevalence in pregnant women, from World Health Organization studies of nutritional anemia (WHO 1968Citation ).

 
The singular importance of iron deficiency was restated with more confidence by Baker and DeMaeyer (1979)Citation : "The major factor responsible [for nutritional anemia] is a deficiency of iron, with folate deficiency also playing a role in some population groups, especially in pregnant women."

In 1985, DeMaeyer and Adiels-Tegman published a landmark paper entitled "The Prevalence of Anemia in the World," in which they compiled global data from reasonably large studies. The data presented in that paper constitute the core of the database used for global prevalence estimates of anemia and iron-deficiency anemia. In that paper, nutritional anemia was considered to be a large component of global anemia prevalence, and iron deficiency was considered the most common cause of nutritional anemia. By making the assumption that the prevalence of anemia in adult men is the amount of anemia not attributable to iron deficiency, the authors tentatively estimated that ~50% of anemia in women and children is attributable to iron deficiency (DeMaeyer and Adiels-Tegman 1985Citation ).

The next evolution of concepts is the shift from nutritional anemia (of which iron-deficiency anemia is one important part) to iron-deficiency anemia as the major public health problem. This is reflected in the title of the 1989 WHO monograph, Preventing and Controlling Iron Deficiency Anaemia Through Primary Health Care, which states (DeMaeyer et al. 1989Citation ), "Iron deficiency anaemia is the most prevalent nutritional disorder in the world today. ... Iron deficiency is by far the commonest nutritional cause of anaemia; it may be associated with a folate deficiency, especially during pregnancy. Other nutrient deficiencies, such as vitamin B-12, pyridoxine (PN) and copper are of little public health significance because of their infrequency."

In 1993, a WHO/United Nations International Children’s Emergency Fund (UNICEF)/United Nations University (UNU) consultation made the next shift in thinking, i.e., from iron-deficiency anemia to iron deficiency as the problem. In the report from that meeting, anemia was considered an indicator of iron deficiency rather than iron deficiency being considered a contributing cause of anemia (WHO/UNICEF/UNU, unpublished). The authors state, "Because anaemia is the most common indicator used to screen for iron deficiency, the terms anaemia, iron deficiency, and iron deficiency anaemia are sometimes used interchangeably. There are, however, mild-to-moderate forms of iron deficiency in which, although anaemia is absent, tissues are still functionally impaired."

However, a more recent meeting in Africa brought the thinking full circle. The lead recommendation from the meeting proceedings reads: "Beyond iron deficiency—focus on anaemia as the principal problem. Even though iron deficiency is a major factor contributing to the anaemia problem in parts of Africa, there are a number of other factors that coexist and contribute to the burden. They include other nutrient deficiencies (e.g., folate, vitamin A), malaria, HIV [human immunodeficiency virus], other infectious diseases, sickle cell disease and other inherited anemias" [Micronutrients Initiative (MI)/UNICEF 1997Citation ].

In the past 3 years, there has been a confusing mixture of language, as illustrated by these three recent expert committee statements: 1) "Iron deficiency is not the only cause of anemia, but where anemia is prevalent, iron deficiency is usually the most common cause" (Stoltzfus and Dreyfuss 1998Citation ). 2) "Anemia has a multifactorial etiology and the contributions of its determinants vary in many ways. Anemia can be caused by dietary factors, malaria, intestinal parasites, HIV, or certain genetic hemoglobinopathies. ... Moreover determinants interact" (Gillespie and Johnston 1998Citation ). 3) "Although iron deficiency accounts for most of the anaemia in underprivileged environments, there are other causes of anaemia. ... As iron deficiency prevalence decreases, other causes of anaemia may become proportionately more important, but excepting sickle-cell anaemia in some populations of Africa, none are at levels requiring a public health response. Successful iron supplementation results in the disappearance of anaemia as a public health problem except where malaria is highly prevalent" (UNICEF/UNU/WHO/MI 1999Citation ).

This confusion has real implications for how we design intervention programs and evaluate their success. It also greatly influences how we estimate the prevalence and distribution of the public health problem, which leads us to our next historical topic.


    WHERE HAVE WE COME FROM? NUMBERS
 TOP
 ABSTRACT
 INTRODUCTION
 WHERE HAVE WE COME...
 WHERE HAVE WE COME...
 WHERE DO WE GO...
 REFERENCES
 
Since 1985, when DeMaeyer and Adiels-Tiegman first attempted to estimate the magnitude of the problem then called nutritional anemia, prevalence estimates have risen dramatically and at a rate exceeding global population growth (Fig. 2Citation ). It is important to consider the fact that all of the estimates that follow are derived from measurements of hemoglobin. Prevalence estimates for iron deficiency or iron-deficiency anemia have been derived from anemia data and are based on a variety of assumptions. Thus, the interpretation of hemoglobin values is fundamentally important. The thinking expressed in a 1972 WHO technical report has been greatly influential: "It is recognized that there is a homeostatic mechanism that sets the hemoglobin level in each individual. Whereas it is not known whether this is the optimum level for health, it is accepted as ‘normal’ for the individual. ... This distribution of normal values is likely to be the same throughout the world when allowance is made for such factors as age, sex, pregnancy, and altitude" (Baker and DeMaeyer 1979Citation ). It is important to remember that the WHO definitions for anemia were explicitly not designed to indicate optimal human function nor to be sensitive or specific for iron deficiency as opposed to other causes. There is also growing opinion that the normative hemoglobin distribution is not the same throughout the world (UNICEF/UNU/WHO/MI 1999Citation ).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Estimates of the number of people in world with anemia, iron-deficiency anemia, or iron deficiency as stated by various expert groups since 1985. References (in chronological order) are the following: DeMaeyer and Adiels-Tegman 1985Citation ; DeMaeyer et al. 1989Citation ; Gillespie et al. 1991Citation ; Levin et al. 1993Citation ; WHO/UNICEF/UNU, unpublished, 1993; Murray and Lopez 1996Citation ; Draper 1997Citation ; Gillespie and Johnston 1998(a)Citation ; Stoltzfus and Dreyfuss 1998(b)Citation ; UNICEF/UNU/WHO/MI 1999Citation ; International Nutritional Anemia Consultative Group 2000Citation .

 
This summary of numbers begins in 1985 (DeMaeyer and Adiels-Tegman 1985Citation ). The 1985 anemia estimate and the 50% attribution of anemia to iron deficiency were cited in two subsequent documents by WHO (DeMaeyer et al. 1989Citation ) and the United Nations Subcommittee on Nutrition (Gillespie et al. 1991Citation ). However in 1993, two documents (Levin et al. 1993Citation , WHO/UNICEF/UNU, unpublished) used De Maeyer and Adiels-Tiegman’s 1985 anemia number but named it iron-deficiency anemia. In 1996, the Global Burden of Disease project adjusted these numbers upward on the basis of a new global population figure but continued to call this the prevalence of iron-deficiency anemia. In 1997–1998, three expert documents used a higher prevalence number of 2.1 billion people affected; Draper (1997)Citation used this as the figure for iron-deficiency anemia, whereas the other documents (Gillespie and Johnson 1998Citation , Stoltzfus and Dreyfuss 1998Citation ) stated this to be the number with iron deficiency. The UNICEF/UNU/WHO/MI (1999)Citation Technical Workshop stated that 3.5 billion people suffer from "iron deficiency and its anemia." Finally, in 1999, a WHO report at an INACG meeting (INACG 2000Citation ) estimated that 2 billion people were anemic (applying the 30% prevalence figure of DeMaeyer and Adiels-Tiegman to a new global population of >6 billion) and tentatively estimated that the number of iron-deficient people could be as high as 5 billion, or 80% of the world’s population. The latter figure was obtained by multiplying the number of anemic people by 2.5. This factor, discussed in the WHO/UNICEF/UNU consultation (unpublished 1993), is based on U.S. national data for women and children, in which the ratio of iron-deficient people to iron-deficient anemic people was 2.5 (Yip 1994Citation ). Applying that figure to global data assumes that this relationship found in the United States is generalizable to the world—a troubling assumption that was clearly acknowledged at the INACG meeting. In addition, the factor should rightly be applied only to the number of iron-deficient anemic people, not to all anemic people.

Thus, in the 15 years since 1985, as our conceptualization of the problem has evolved from iron-deficiency anemia to become iron deficiency with or without anemia, the number of people supposedly affected has grown from 0.6 million to 3.5–5 million. When global population growth is controlled for, prevalence estimates have risen from 15 to 60–80% of the world’s population. I suggest to you that these estimates have become incredible.


    WHERE DO WE GO FROM HERE?
 TOP
 ABSTRACT
 INTRODUCTION
 WHERE HAVE WE COME...
 WHERE HAVE WE COME...
 WHERE DO WE GO...
 REFERENCES
 
The purpose of this meeting is to begin to redefine the public health problem of iron deficiency on the basis of empirical evidence linking the potential risk factors (e.g., iron deficiency or iron-deficiency anemia) to important health consequences. Our goal is to define the problem in terms that are important, measurable and addressable. The point is not to generate the largest prevalence estimates that we can. Incredibly large prevalence estimates have not brought about public health success in this area in the past decade. The point is to create a basis for prevalence estimates that we can measure and that represent real and important health risks.

Public health scientists and practitioners working on the problem of iron-deficiency anemia have lamented two challenges, i.e., it is difficult to rally political support for the problem and it is difficult to demonstrate success in controlling it. Our reaction to the first problem has been to hold more meetings and advocate more vociferously. Our reaction to the second problem has been to question our interventions and their efficacy. It is possible that a clearer and more compelling definition of the problem could contribute greatly to meeting both of these challenges. If we define the problem in terms of functional consequences rather than normative indicator distributions, our advocacy to the international health community may be more effective. If we set goals and evaluate programs on the basis of concepts and biological processes that are clear and measurable, we might find that our interventions are more successful than we have documented in the past.

I suggest that at least four steps are key to this process. The first step is to identify the causal factor. What is it that causes functional deficits (i.e., disease, disability or death) in humans? Is it iron deficiency per se? Iron-deficiency anemia? Severe anemia from any cause? The second step is to estimate the magnitude of its effect on important public health outcomes. How large are the relative risks or other measures of effect size? The third step is to estimate the prevalence of the causal factor, and the fourth step is to demonstrate effective ways to reduce the causal factor or to interrupt its link to adverse health consequences. The papers that follow address the first two steps in this process.

John Beard and Lindsay Allen present background papers that describe what we know about the possible causal factors and how they affect human physiology in the relevant outcome domains. Bernard Brabin, Kathleen Rasmussen, Stephen Oppenheimer, Sally Grantham-McGregor and Jere Haas present critical reviews of the causal evidence that links iron deficiency, anemia or both to the six outcome areas. Additional commentaries by Sue Horton and Carol Levin on work productivity and Ernesto Pollitt on child development are included with the respective evidence reviews. The supplement concludes with a summary of how the meeting participants synthesized the evidence.


    FOOTNOTES
 
1 Presented at the Belmont Meeting on Iron Deficiency Anemia: Reexamining the Nature and Magnitude of the Public Health Problem, held May 21–24, 2000 in Belmont, MD. The proceedings of this conference are published as a supplement to The Journal of Nutrition. Supplement guest editors were John Beard, The Pennsylvania State University, University Park, PA and Rebecca Stoltzfus, Johns Hopkins School of Public Health, Baltimore, MD. Back

2 This article was commissioned by the World Health Organization (WHO). The views expressed are those of the author alone and do not necessarily reflect those of WHO. Back

3 Abbreviations: HIV, human immunodeficiency virus; INACG, International Nutritional Anemia Consultative Group; MI, Micronutrients Initiative; UNICEF, United National International Children’s Emergency Fund; UNU, United Nations University. Back


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 WHERE HAVE WE COME...
 WHERE HAVE WE COME...
 WHERE DO WE GO...
 REFERENCES
 

1. Baker S. J., DeMaeyer E. M. Nutritional anemia: its understanding and control with special reference to the work of the World Health Organization. Am. J. Clin. Nutr. 1979;32:368-417[Abstract/Free Full Text]

2. DeMaeyer E. M., Adiels-Tegman M. The prevalence of anaemia in the world. Rapp. Trimest. Stat. Sanit. Mond. 1985;38:302-316

3. DeMaeyer E. M., Dallman P., Gurney J. M., Hallberg L., Sood S. K., Srikantia S. G. Preventing and controlling iron deficiency anaemia through primary health care: a guide for health administrators and programme managers 1989:5-58 WHO Geneva, Switzerland.

4. Draper A. Child development and iron deficiency 1997:1-6 The Oxford Brief, INACG (International Nutritional Anemia Consultative Group) Washington, DC.

5. Gillespie S., Johnston J. L. Expert Consultation on Anemia Determinants and Interventions 1998:1-37 Micronutrient Initiative Ottawa, Canada.

6. Gillespie S., Kevany J., Mason J. Controlling iron deficiency 1991:1-93 United Nations Administrative Committee on Coordination, Sub-Committee on Nutrition Geneva, Switzerland.

7. International Nutritional Anemia Consultative Group (2000) INACG Symposium. 12 March 1999, Durban South Africa, pp. 1–60. ILSI Research Foundation, Washington, DC.

8. Levin H. M., Pollitt E., Galloway R., McGuire J. Micronutrient deficiency disorders. Jamison D. T. Mosley W. H. eds. Disease Control Priorities in Developing Countries 1993 Oxford University Press (World Bank) New York, NY.

9. Micronutrients Initiative/UNICEF Proceedings of the eastern and southern Africa regional consultation on anemia 1997 Micronutrients Initiative Ottawa, Canada.

10. Murray C. J., Lopez A. D. Global Health Statistics 1996:1-906 Harvard University Press Cambridge, MA.

11. Stoltzfus R. J., Dreyfuss M. L. Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia 1998:1-39 ILSI Press Washington DC.

12. UNICEF/UNU/WHO/MI Preventing Iron Deficiency in Women and Children, Technical Consensus on Key Issues 1999:1-60 International Nutrition Foundation Boston, MA.

13. World Health Organization Nutritional anaemias: report of a WHO Scientific Group 1968 WHO Geneva, Switzerland.

14. Yip R. Iron deficiency: contemporary scientific issues and international programmatic approaches. J. Nutr. 1994;124:1479S-1490S




This article has been cited by other articles:


Home page
J Pediatr PsycholHome page
F. Corapci, A. Calatroni, N. Kaciroti, E. Jimenez, and B. Lozoff
Longitudinal Evaluation of Externalizing and Internalizing Behavior Problems Following Iron Deficiency in Infancy
J. Pediatr. Psychol., September 7, 2009; (2009) jsp065v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Young, R. P Glahn, M. Ariza-Nieto, J. Inglis, G. Olbina, M. Westerman, and K. O O'Brien
Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 533 - 538.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
S. F. Clark
Iron Deficiency Anemia
Nutr Clin Pract, April 1, 2008; 23(2): 128 - 141.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
J. M. Brotanek, J. Gosz, M. Weitzman, and G. Flores
Secular Trends in the Prevalence of Iron Deficiency Among US Toddlers, 1976-2002
Arch Pediatr Adolesc Med, April 1, 2008; 162(4): 374 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Kupka, G. I. Msamanga, F. Mugusi, P. Petraro, D. J. Hunter, and W. W. Fawzi
Iron Status Is an Important Cause of Anemia in HIV-Infected Tanzanian Women but Is Not Related to Accelerated HIV Disease Progression
J. Nutr., October 1, 2007; 137(10): 2317 - 2323.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
M. J. ELIADES, A. WOLKON, K. MORGAH, S. B. CRAWFORD, A. DORKENOO, Y. SODAHLON, W. A. HAWLEY, A. W. HIGHTOWER, F. O. T. KUILE, and D. J. TERLOUW
Burden of malaria at community level in children less than 5 years of age in togo.
Am J Trop Med Hyg, October 1, 2006; 75(4): 622 - 629.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Meyerovitch, M. Sherf, F. Antebi, M. Barhoum-Noufi, Z. Horev, L. Jaber, D. Weiss, and A. Koren
The Incidence of Anemia in an Israeli Population: A Population Analysis for Anemia in 34512 Israeli Infants Aged 9 to 18 Months
Pediatrics, October 1, 2006; 118(4): e1055 - e1060.
[Abstract] [Full Text] [PDF]


Home page
Qual Health ResHome page
B. Turnbull, G. Martinez-Andrade, M. Klunder, T. Carranco, X. Duque-Lopez, R. I. Ramos-Hernandez, M. Gonzalez-Unzaga, S. Flores-Hernandez, and H. Martinez-Salgado
The Social Construction of Anemia in School Shelters for Indigenous Children in Mexico
Qual Health Res, April 1, 2006; 16(4): 503 - 516.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. P. McClung, L. J. Marchitelli, K. E. Friedl, and A. J. Young
Prevalence of Iron Deficiency and Iron Deficiency Anemia among Three Populations of Female Military Personnel in the US Army.
J. Am. Coll. Nutr., February 1, 2006; 25(1): 64 - 69.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. A Thurlow, P. Winichagoon, T. Green, E. Wasantwisut, T. Pongcharoen, K. B Bailey, and R. S Gibson
Only a small proportion of anemia in northeast Thai schoolchildren is associated with iron deficiency
Am. J. Clinical Nutrition, August 1, 2005; 82(2): 380 - 387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. M Black, A. H Baqui, K Zaman, L. Ake Persson, S. El Arifeen, K. Le, S. W McNary, M. Parveen, J. D Hamadani, and R. E Black
Iron and zinc supplementation promote motor development and exploratory behavior among Bangladeshi infants
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 903 - 910.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
L. E. CAULFIELD, S. A. RICHARD, and R. E. BLACK
UNDERNUTRITION AS AN UNDERLYING CAUSE OF MALARIA MORBIDITY AND MORTALITY IN CHILDREN LESS THAN FIVE YEARS OLD
Am J Trop Med Hyg, August 1, 2004; 71(2_suppl): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. R. Desai, R. Dhar, D. H. Rosen, S. K. Kariuki, Y. P. Shi, P. A. Kager, and F. O. ter Kuile
Daily Iron Supplementation Is More Efficacious than Twice Weekly Iron Supplementation for the Treatment of Childhood Anemia in Western Kenya
J. Nutr., May 1, 2004; 134(5): 1167 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. J Terlouw, M. R Desai, K. A Wannemuehler, S. K Kariuki, C. M Pfeiffer, P. A Kager, Y. P. Shi, and F. O ter Kuile
Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. Shell-Duncan and T. McDade
Use of Combined Measures from Capillary Blood to Assess Iron Deficiency in Rural Kenyan Children
J. Nutr., February 1, 2004; 134(2): 384 - 387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Villalpando, M. E Latulippe, G. Rosas, M. J. Irurita, M. F. Picciano, and D. L O'Connor
Milk folate but not milk iron concentrations may be inadequate for some infants in a rural farming community in San Mateo, Capulhuac, Mexico
Am. J. Clinical Nutrition, October 1, 2003; 78(4): 782 - 789.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. Lozoff, I. De Andraca, M. Castillo, J. B. Smith, T. Walter, and P. Pino
Behavioral and Developmental Effects of Preventing Iron-Deficiency Anemia in Healthy Full-Term Infants
Pediatrics, October 1, 2003; 112(4): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Cook, C. H. Flowers, and B. S. Skikne
The quantitative assessment of body iron
Blood, May 1, 2003; 101(9): 3359 - 3363.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. W. McDade and B. Shell-Duncan
Whole Blood Collected on Filter Paper Provides a Minimally Invasive Method for Assessing Human Transferrin Receptor Level
J. Nutr., December 1, 2002; 132(12): 3760 - 3763.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Zlotkin and P. Arthur
Reply to NW Solomons and K Schumann
Am. J. Clinical Nutrition, September 1, 2002; 76(3): 693 - 694.
[Full Text] [PDF]


Home page
J. Nutr.Home page
R. Yip
Prevention and Control of Iron Deficiency: Policy and Strategy Issues
J. Nutr., April 1, 2002; 132(4): 802S - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. H. Allen
Iron Supplements: Scientific Issues Concerning Efficacy and Implications for Research and Programs
J. Nutr., April 1, 2002; 132(4): 813S - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. Nantel and K. Tontisirin
Policy and Sustainability Issues
J. Nutr., April 1, 2002; 132(4): 839S - 844.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Trowbridge and R. Martorell
Summary and Recommendations
J. Nutr., April 1, 2002; 132(4): 875S - 879.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoltzfus, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoltzfus, R. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2001 by American Society for Nutrition